Compass Pathways
The Director, Payer Marketing at Compass Pathways leads the development of US market access strategies and payer engagement assets for the launch of COMP360, a novel mental health treatment. This role involves creating value propositions, collaborating with cross-functional teams including Medical Affairs and HEOR, and building models to support early product access across commercial and government segments. The position requires deep expertise in the healthcare ecosystem to drive optimal coverage and reimbursement for this investigational psilocybin therapy.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2016
Compass Pathways is a biotechnology company developing psilocybin-based therapies for treatment-resistant depression and other serious mental health conditions. It conducts clinical research and develops treatment models that combine psychedelic compounds with psychological support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Compass Pathways.
9% above the average for this role
BREAKING: Second Positive Phase 3 for Compass' Psilocybin, Though Modest Magnitude Raises Questions
3 weeks ago
US Market Access & Reimbursement Director
Intuitive
Principal US Market Access and Reimbursement Specialist
Intuitive
Health Economics, Policy and Reimbursement Program Manager
Medtronic
Senior Director, Field Access (Field Based)
Insulet
Senior Director Market Access (Diagnostics – Women’s Health & Reproductive Genetics)
Labcorp
VP of Access Strategy & Payer Engagement
Ocular Therapeutix